Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Patient safety

Electronic medication systems risk patient safety if not implemented properly, safety body warns

A report from the independent Healthcare Safety Investigation Branch has highlighted the risk to patient safety using the case of a patient who was prescribed two anticoagulants at once. 

Electronic medication systems risk patient safety if not implemented properly, safety body warns

Source: Shutterstock.com

The Healthcare Safety Investigation Branch report highlights the importance of errors in communication between providers using different systems for patient records and prescriptions

Incomplete use of electronic medication systems, such as electronic prescribing and medicines administration (ePMA), can risk patient safety, a report from the independent Healthcare Safety Investigation Branch (HSIB) has found.

The report, ‘Electronic prescribing and medicines administration systems and safe discharge’, published on 24 October 2019, followed an incident that led to a patient taking two anticoagulants at once owing to a lack of information shared about the patient’s medicines on discharge from hospital.

In the case, a 75-year-old woman with incurable cancer, who was already taking the anticoagulant dalteparin for atrial fibrillation, was admitted to hospital.

On discharge, her prescription for dalteparin was stopped on the trust’s ePMA system and she was prescribed apixaban instead. However, on visiting her local pharmacy after being discharged, she still received her repeat prescription for dalteparin. This followed an order of dalteparin submitted the previous week, which she then took on top of the newly prescribed apixaban.

The error was detected 15 days after discharge by a hospice nurse and both medicines were stopped by the patient’s GP. She died three days later, although her death was not caused by the error.

The HSIB said the example highlighted the risks to patients cared for by more than one healthcare provider, caused by errors in communication between providers using different systems for patient records and prescriptions.

“ePMA systems are a positive step for the NHS — research shows if implemented well they can reduce medication errors by 50%,” said Stephen Drage, director of investigations at HSIB.

“Our report is highlighting the risks if e-prescribing is not fully integrated and doesn’t create the whole picture of the patient’s medication needs, from when they arrive to when they return home.

“The safety recommendations we’ve made are asking for national bodies to provide trusts with a blueprint for what a good system and implementation should look like. This will mean ePMA systems are used to their full benefit, reducing the risk of serious harm to patients.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207240

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Essentials of Economic Evaluation in Healthcare

    Essentials of Economic Evaluation in Healthcare

    An introduction to economic evaluation specific to healthcare, for those with little or no knowledge of economics. Covers cost effectiveness, cost utility and cost benefit analysis.

    £33.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.